A Rare Case of NUT Carcinoma of the Thyroid

Author:

Cadesky Adam1ORCID,Schulman-Rosenbaum Rifka1,Carter Amanda2,Paul Elizabeth1,Jaggi Shuchie1

Affiliation:

1. Department of Medicine, Division of Endocrinology, Metabolism & Diabetes, Northwell , New Hyde Park, NY 11042-1069 , USA

2. Division of Endocrinology, Diabetes & Metabolism, NYU Langone Health , Manhasset, NY 11030 , USA

Abstract

Abstract NUT carcinoma is an aggressive, poorly differentiated squamous cell carcinoma, defined by rearrangement of the NUTM1 (Nuclear Protein in Testis) gene. Diagnosis is challenging due to histologic similarities with other poorly differentiated tumors requiring advanced diagnostic techniques. There is no established treatment, and prognosis remains extremely poor. A 27-year-old woman without known medical history presented with a rapidly enlarging neck mass and compressive symptoms. Chemotherapy for presumed squamous cell carcinoma with a component of anaplastic thyroid cancer based on pathology was initiated. Next-generation sequencing revealed thyroid NUT carcinoma with high PD-L1 expression, prompting PD-1 targeted therapy. The patient expired shortly afterwards from progressive disease. NUT carcinoma of thyroid origin is an extremely rare disease. This case brings awareness to the disease, highlights the importance of advanced diagnostic techniques and complexities in managing patients with NUT carcinoma.

Publisher

The Endocrine Society

Reference22 articles.

1. NUT carcinoma: clinicopathologic features, pathogenesis, and treatment;French;Pathol Int,2018

2. Clinicopathologic features and long-term outcomes of NUT midline carcinoma;Bauer;Clin Cancer Res,2012

3. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients;Chau;JNCI Cancer Spectrum,2019

4. NUT carcinoma of the thyroid: an unusual case with a complete response to treatment;Kuo;Clin Thyroidol,2021

5. Possible primary thyroid nuclear protein in testis carcinomas with NSD3::NUTM1 translocation revealed by RNA sequencing: a report of two cases;Scherman;Thyroid,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3